test

Sean Aurigemma

@Pier 88 Investment Partners Llc

Latest period2024 - Q3ReportedManaged Assets$453.922MTotal holdings91
Assets growth rate1.78%Assets growth rate (2-Q avg)5.69%Continuous growth in asset value3 quarters

Portfolio positions

This chart displays the top 10 holdings in Pier 88 Investment Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 91 positions.

Assets under management

The assets under management (AUM) of Pier 88 Investment Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 453.922M in assets, with a quarterly growth rate of 1.78% and a 2-quarter average growth rate of 5.69%. The portfolio is managed by Sean Aurigemma, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ENTGEntegris Inc
Recent Activity
Decreased -16%
0.2%
$885,611
7,870 shares@ $112.53 avg price
FPIFarmland Partners Inc
Recent Activity
Decreased -51.12%
0.13%
$589,903
56,450 shares@ $10.46 avg price
TWTradeweb Mkts Inc
Recent Activity
Decreased -20.98%
0.13%
$568,264
4,595 shares@ $123.68 avg price
ABSIAbsci Corporation
Recent Activity
Decreased -8.16%
0.12%
$519,978
136,120 shares@ $3.82 avg price
OKTAOkta Inc
Recent Activity
Decreased -45.44%
0.11%
$494,361
6,650 shares@ $74.34 avg price
DXCMDexcom Inc
Recent Activity
Decreased -53.04%
0.1%
$429,056
6,400 shares@ $67.04 avg price
IOVAIovance Biotherapeutics Inc
Recent Activity
Decreased -24.58%
0.1%
$414,850
44,180 shares@ $9.39 avg price
HUBSHubspot Inc
Recent Activity
Decreased -64.9%
0.09%
$388,068
730 shares@ $531.6 avg price
NBIXNeurocrine Biosciences Inc
Recent Activity
Decreased -12.95%
0.08%
$356,030
3,090 shares@ $115.23 avg price
TXG10x Genomics Inc
Recent Activity
Decreased -1.69%
0.07%
$288,572
12,780 shares@ $22.58 avg price